Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroskin Forte for Dry Skin in Psoriasis and Eczema
NCT00143819Phase 2Terminated
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Sep 2005
- Primary completion
- Feb 2010
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in psoriasis and Eczema comparing Neuroskin Forte with Placebo (2 arms). Primary endpoint: Visual Analog Scale Score for Pruritus at 8 weeks. Started Sep 2005; status: terminated.
02
Drugs
neuroskin forte
03
Conditions
psoriasisEczema
Beyond the preview
Go deeper on NCT00143819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00143819.